Likewise, other studies have shown the same reduction in Akt phosphorylation in human glioma and neuroblastoma lines and murine astrocytes, when using a synthetic cannabinoid (WIN 55,212-2) and CBD [38,41,48]. The gene discussed is AKT1; the disease is glioma.